• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Tevogen Bio Holdings Inc. - Common Stock (NQ: TVGN )

    0.7640 +0.0090 (+1.19%)
    Streaming Delayed Price Updated: 12:34 PM EDT, Jun 21, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 23,980
    Open 0.7577
    Bid (Size) 0.7640 (2)
    Ask (Size) 0.7700 (9)
    Prev. Close 0.7550
    Today's Range 0.7577 - 0.7780
    52wk Range 0.7500 - 21.09
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Tevogen.AI Head Discusses Company’s Bold Strategy to Shape the Future of T Cell Therapies at Longwood Spring MIT Conference
    From Tevogen Bio Inc
    Via GlobeNewswire
    Tevogen Bio Set to Join Russell 3000® Index
    From Tevogen Bio Inc
    Via GlobeNewswire

    Performance

    YTD
    -92.36%
    -92.36%
    1 Month
    -11.16%
    -11.16%
    3 Month
    -82.11%
    -82.11%
    6 Month
    -92.36%
    -92.36%
    1 Year
    -92.36%
    -92.36%

    More News

    Read More
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Why Is Tevogen Bio (TVGN) Stock Up 54% Today?
    Via InvestorPlace
    Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts
    From Tevogen Bio Inc
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    CORRECTION – Tevogen Bio Expresses Gratitude to Patients, First Responders, Elected Officials, and Members of the United States Congress for Attending Its Inaugural Post-Public Listing Social Engagement Event
    From Tevogen Bio Inc
    Via GlobeNewswire
    Tevogen Bio Expresses Gratitude to Patients, First Responders, Elected Officials, and Members of the United States Congress for Attending Its Inaugural Post-Listing Social Engagement Event
    From Tevogen Bio Inc
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Tevogen Bio Confirms Ongoing Efficacy of TVGN 489, Its Investigational Allogeneic Off-the-Shelf Immunotherapy, Against Dominant FLiRT Strains of SARS-CoV-2
    From Tevogen Bio Inc
    Via GlobeNewswire
    TVGN Stock Earnings: Tevogen Bio Holdings Reported Results for Q1 2024
    Via InvestorPlace
    Tevogen Bio Reports First Quarter 2024 Financial Results
    From Tevogen Bio Inc
    Via GlobeNewswire
    Why Larimar Therapeutics Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Tevogen Bio Appoints Former Police Chief & FBI National Academy Graduate, William Keane, as Vice President of Strategic Initiatives
    From Tevogen Bio Inc
    Via GlobeNewswire
    Why Akoustis Technologies Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Why Tevogen Bio Holdings Stock Is Moving Higher Today
    Via Benzinga
    Why Is TransCode Therapeutics (RNAZ) Stock Down 14% Today?
    Via InvestorPlace
    Why Is Safe & Green Development (SGD) Stock Down 5% Today?
    Via InvestorPlace
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    Why Is AC Immune (ACIU) Stock Up 45% Today?
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    Why JanOne Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational Objectives
    From Tevogen Bio Inc
    Via GlobeNewswire
    Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.